T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial

Katie J. Ewer,Jordan R. Barrett,Sandra Belij-Rammerstorfer,Hannah Sharpe,Rebecca Makinson,Richard Morter,Amy Flaxman,Daniel Wright,Duncan Bellamy,Mustapha Bittaye,Christina Dold,Nicholas M. Provine,Jeremy Aboagye,Jamie Fowler,Sarah E. Silk,Jennifer Alderson,Parvinder K. Aley,Brian Angus,Eleanor Berrie,Sagida Bibi,Paola Cicconi,Elizabeth A. Clutterbuck,Irina Chelysheva,Pedro M. Folegatti,Michelle Fuskova,Catherine M. Green,Daniel Jenkin,Simon Kerridge,Alison Lawrie,Angela M. Minassian,Maria Moore,Yama Mujadidi,Emma Plested,Ian Poulton,Maheshi N. Ramasamy,Hannah Robinson,Rinn Song,Matthew D. Snape,Richard Tarrant,Merryn Voysey,Marion E. E. Watson,Alexander D. Douglas,Adrian V. S. Hill,Sarah C. Gilbert,Andrew J. Pollard,Teresa Lambe,Aabidah Ali,Elizabeth Allen,Megan Baker,Eleanor Barnes,Nicola Borthwick,Amy Boyd,Charlie Brown-O’Sullivan,Joshua Burgoyne,Nicholas Byard,Ingrid Cabrera Puig,Federica Cappuccini,Jee-Sun Cho,Elizabeth Clark,Wendy E. M. Crocker,Mehreen S. Datoo,Hannah Davies,Francesca R. Donnellan,Susanna Jane Dunachie,Nick J. Edwards,Sean C. Elias,Julie Furze,Ciaran Gilbride,Giacomo Gorini,Gaurav Gupta,Stephanie A. Harris,Susanne H. C. Hodgson,Mimi M. Hou,Susan Jackson,Kathryn Jones,Reshma Kailath,Lloyd King,Colin W. Larkworthy,Yuanyuan Li,Amelia M. Lias,Aline Linder,Samuel Lipworth,Raquel Lopez Ramon,Meera Madhavan,Emma Marlow,Julia L. Marshall,Alexander J. Mentzer,Hazel Morrison,Nathifa Moya,Ekta Mukhopadhyay,Andrés Noé,Fay L. Nugent,Dimitra Pipini,David Pulido-Gomez,Fernando Ramos Lopez,Adam John Ritchie,Indra Rudiansyah,Stephannie Salvador,Helen Sanders,Iman Satti,Adam Shea,Sarah Silk,Alexandra J. Spencer,Rachel Tanner,Iona Jennifer Taylor,Yrene Themistocleous,Merin Thomas,Nguyen Tran,Adam Truby,Cheryl Turner,Nicola Turner,Marta Ulaszewska,Andrew T. Worth,Lucy Kingham-Page,Marco Polo Peralta Alvarez,Rachel Anslow,Louise Bates,Kirsten Beadon,Rebecca Beckley,Amy Beveridge,Else Margreet Bijker,Luke Blackwell,Jamie Burbage,Susana Camara,Melanie Carr,Rachel Colin-Jones,Rachel Cooper,Christina J. Cunningham,Tesfaye Demissie,Claudio Di Maso,Naomi Douglas,Rachael Drake-Brockman,Ruth Elizabeth Drury,Katherine R. W. Emary,Sally Felle,Shuo Feng,Carla Ferreira Da Silva,Karen J. Ford,Emma Francis,Lara Gracie,Joseph Hamlyn,Brama Hanumunthadu,Daisy Harrison,Thomas C. Hart,Sophia Hawkins,Jennifer Hill,Elizabeth Howe,Nicola Howell,Elizabeth Jones,Jade Keen,Sarah Kelly,David Kerr,Liaquat Khan,Jasmin Kinch,Stanislava Koleva,Emily A. Lees,Alice Lelliott,Xinxue Liu,Natalie G. Marchevsky,Spyridoula Marinou,Joanne McEwan,Ella Morey,Gertraud Morshead,Jilly Muller,Claire Munro,Sarah Murphy,Philomena Mweu,Elizabeth Nuthall,Katie O’Brien,Daniel O’Connor,Peter John O’Reilly,Blanché Oguti,Piper Osborne,Nelly Owino,Kaye Parker,Katja Pfafferott,Daniel Phillips,Samuel Provstgaard-Morys,Helen Ratcliffe,Thomas Rawlinson,Sarah Rhead,Hannah Roberts,Katherine Sanders,Laura Silva-Reyes,Christine S. Rollier,Catherine C. Smith,David J. Smith,Lisa Stockdale,Anna Szigeti,Tonia M. Thomas,Amber Thompson,Adriana Tomic,Susan Tonks,Rachel Varughese,Marije K. Verheul,Iason Vichos,Laura Walker,Caroline White,Rachel White,Xin Li Yao,Christopher P. Conlon,John Frater,Liliana Cifuentes,Ioana Baleanu,Emma Bolam,Elena Boland,Tanja Brenner,Brad E. Damratoski,Chandra Datta,Omar El Muhanna,Richard Fisher,Pablo Galian-Rubio,Gina Hodges,Frederic Jackson,Shuchang Liu,Lisa Loew,Roisin Morgans,Susan Jane Morris,Vicki Olchawski,Catarina Oliveria,Helena Parracho,Emilia Reyes Pabon,Abdessamad Tahiri-Alaoui,Keja Taylor,Paul Williams,Dalila Zizi,Edward H. Arbe-Barnes,Philip Baker,Alexander Batten,Charlotte Downing,Jonathan Drake,Marcus Rex English,John Aaron Henry,Poppy Iveson,Annabel Killen,Thomas B. King,Jessica P. J. Larwood,Garry Mallett,Kushal Mansatta,Neginsadat Mirtorabi,Maia Patrick-Smith,James Perring,Kajal Radia,Sophie Roche,Ella Schofield,Rebecca te Water Naude,James Towner,Natalie Baker,Kevin R. Bewley,Emily Brunt,Karen R. Buttigieg,Miles W. Carroll,Sue Charlton,Naomi S. Coombes,Michael J. Elmore,Kerry Godwin,Bassam Hallis,Daniel Knott,Lorna McInroy,Imam Shaik,Kelly Thomas,Julia A. Tree,Caitlin L. Blundell,Michelangelo Cao,Dearbhla Kelly,Annina Schmid,Donal T. Skelly,Andreas Themistocleous,Tao Dong,Samantha Field,Elizabeth Hamilton,Elizabeth Kelly,Paul Klenerman,Julian C. Knight,Yolanda Lie,Christos Petropoulos,Cynthia Sedik,Terri Wrin,Gretchen Meddaugh,Yanchun Peng,Gavin Screaton,Elizabeth Stafford,
DOI: https://doi.org/10.1038/s41591-020-01194-5
IF: 82.9
2020-12-17
Nature Medicine
Abstract:Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of Coronavirus Disease 2019 (COVID-19), has caused a global pandemic, and safe, effective vaccines are urgently needed<sup><a href="/articles/s41591-020-01194-5#ref-CR1">1</a></sup>. Strong, Th1-skewed T cell responses can drive protective humoral and cell-mediated immune responses<sup><a href="/articles/s41591-020-01194-5#ref-CR2">2</a></sup> and might reduce the potential for disease enhancement<sup><a href="/articles/s41591-020-01194-5#ref-CR3">3</a></sup>. Cytotoxic T cells clear virus-infected host cells and contribute to control of infection<sup><a href="/articles/s41591-020-01194-5#ref-CR4">4</a></sup>. Studies of patients infected with SARS-CoV-2 have suggested a protective role for both humoral and cell-mediated immune responses in recovery from COVID-19 (refs. <sup><a href="/articles/s41591-020-01194-5#ref-CR5">5</a>,<a href="/articles/s41591-020-01194-5#ref-CR6">6</a></sup>). ChAdOx1 nCoV-19 (AZD1222) is a candidate SARS-CoV-2 vaccine comprising a replication-deficient simian adenovirus expressing full-length SARS-CoV-2 spike protein. We recently reported preliminary safety and immunogenicity data from a phase 1/2 trial of the ChAdOx1 nCoV-19 vaccine (NCT04400838)<sup><a href="/articles/s41591-020-01194-5#ref-CR7">7</a></sup> given as either a one- or two-dose regimen. The vaccine was tolerated, with induction of neutralizing antibodies and antigen-specific T cells against the SARS-CoV-2 spike protein. Here we describe, in detail, exploratory analyses of the immune responses in adults, aged 18–55 years, up to 8 weeks after vaccination with a single dose of ChAdOx1 nCoV-19 in this trial, demonstrating an induction of a Th1-biased response characterized by interferon-γ and tumor necrosis factor-α cytokine secretion by CD4<sup>+</sup> T cells and antibody production predominantly of IgG1 and IgG3 subclasses. CD8<sup>+</sup> T cells, of monofunctional, polyfunctional and cytotoxic phenotypes, were also induced. Taken together, these results suggest a favorable immune profile induced by ChAdOx1 nCoV-19 vaccine, supporting the progression of this vaccine candidate to ongoing phase 2/3 trials to assess vaccine efficacy.
biochemistry & molecular biology,cell biology,medicine, research & experimental
What problem does this paper attempt to address?